Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety.
Biotechnol Healthc. 2012 Spring;9(1):24-7. Biotechnol Healthc. 2012. PMID: 22606078 Free PMC article.